Stock comparison
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NEOG is larger
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B).
Market value leader
NEOG
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B).
Revenue leader
NEOG
NEOG: $894.66M vs NNNN: $8.65M.
Profit leader
NNNN
NEOG: -$1.09B vs NNNN: $6.40M.
Margin leader
NNNN
NEOG: -122.1% vs NNNN: 74.1% net margin.
| Metric | NEOG | NNNN |
|---|---|---|
| Market cap | $2.12 B | $1.50 B |
| US-listed rank | #2092 | #2355 |
| Revenue (latest FY) | $894.66M | $8.65M |
| Net income (latest FY) | -$1.09B | $6.40M |
| Net margin | -122.1% | 74.1% |
| P/E (trailing FY) | - | 234.2x |
| SEC filings | 1,894 | 40 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
NEOGEN CORP is 1.4x more valuable than Anbio Biotechnology by market capitalization ($2.12 B vs $1.50 B).
In their latest fiscal years, NEOGEN CORP reported $894.66M in revenue while Anbio Biotechnology reported $8.65M.
Full pages: NEOGEN CORP and Anbio Biotechnology, or browse the full rankings.